共 17 条
[1]
Belvis A., Pelone F., Biasco A., Ricciardi W., Volpe M., Can primary care professionals’ adherence to Evidence Based Medicine tools improve quality of care in Type 2 diabetes mellitus? A systematic review, Diabetes Res. Clin. Pract, 85, pp. 119-131, (2009)
[2]
Tripathi K.D., Essentials of Medical Pharmacology, pp. 167-184, (2003)
[3]
Standards of Medical Care in Diabetes, Diabetes Care, 31, 1, (2008)
[4]
Keilson L., Mather S., Walter Y.H., Subramanian S., McLeod J.F., Determination of nateglinide in human plasma by highperformance liquid chromatography with pre-column derivatization using a coumarin-type fluorescent reagent, J. Clin Endocrinol. Metab, 85, (2000)
[5]
Weaver M.L., Orwig B.A., Rodriguez L.C., Pharmacokinetics and metabolism of nateglinide in humans, Drug Metab. Dispos, 29, pp. 415-421, (2001)
[6]
Takesada H., Matsuda K., Ohtake R., Structure determination of metabolites isolated from urine and bile after administration of AY4166, a novel D-phenylalanine derivative hypoglycemic agent, Bioorg. Med. Chem, 4, pp. 1771-1781, (1996)
[7]
Murthy R., Biodegradable polymers, Controlled and Novel Drug Delivery, pp. 27-51, (1997)
[8]
Sinha V.R., Bansal K., Kaushik R., Kumria R., Trehan A., Poly- _-caprolactone microspheres and nanospheres: An overview, Int. J Pharm, 278, pp. 1-23, (2004)
[9]
Lokhande A.B., Mishra S., Kulkarni R.D., Naik J.B., Preparation and characterization of repaglinide loaded ethylcellulose nanopaticles by solvent diffusion technique using High pressure homogenizer, J. Pharm. Res, 7, pp. 421-426, (2013)
[10]
Khairnar G., Mokale M., Naik J., Formulation and development of nateglinide loaded sustained release ethyl cellulose microspheres by O/W solvent emulsification technique, J. Pharm. Invest, 44, pp. 411-422, (2014)